All News Avacta Group Plc

Equities

Market Closed - London S.E. Other stock markets 09:05:07 03/05/2024 pm IST			5-day change	1st Jan Change
45.5 ^GBX	-2.15%		-6.76%	-60.94%

01/05	Avacta picks Christina Coughlin to replace long-serving CEO	AN
30/04	EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	AN

Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	01/05	AQ
Avacta picks Christina Coughlin to replace long-serving CEO	01/05	AN
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	30/04	AN
Avacta Group CEO Steps Down; Successor Appointed	30/04	MT
Transcript : Avacta Group Plc, 2023 Earnings Call, Apr 30, 2024	30/04
Avacta : Results for the Year Ended 31 December 2023	30/04	PU
Avacta : Preliminary Results for the Year Ended 31 December 2023	30/04	PU
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	30/04	PU
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Avacta Group plc Announces Chief Executive Officer Changes	30/04	CI
Avacta : R&D Spotlight series – Episode 2	25/04	PU
Avacta Group plc - Block Listing Application to AIM	24/04	AQ
Avacta Group plc - Notice of Results	24/04	AQ
First Tin updates Tellerhauser estimates	22/04	AN
Transcript : Avacta Group Plc - Special Call	10/04
Avacta Therapeutics Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 at the AACR Annual Meeting Demonstrating Clinical Proof-of-Concept Showing Multiple Patient Responses	10/04	AQ
Avacta Group plc Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 At the AACR Annual Meeting	09/04	CI
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update	06/04	GL
Avacta : Glossary	05/04	PU
Avacta : Research and Development Spotlight Series – Episode 1	27/03	PU

No results for this search